Allogeneic Stem Cell Transplantation clinical trials

Explore recruiting allogeneic stem cell transplantation clinical trials.

Recruiting allogeneic stem cell transplantation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Allogeneic Stem Cell Transplantation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Treatment of chemo-refractory viral infections after allogeneic stem cell transplantation with multispecific T cells against CMV, EBV and AdV: A phase III, prospective, multicentre clinical trial (TRACE)

Belgium, Germany, Italy, France, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

TAGVEN "Open label phase II study evaluating the efficacy and safety of the combination of tagraxofusp and venetoclax in treatment-naive blastic plasmacytoid dendritic cell neoplasm patients"

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A prospective, open-label, randomized, multicenter phase-III trial to evaluate the efficacy of pirtobrutinib and epcoritamab compared with R-(mini)-CHOP for treatment of patients with Richter Transformation - CLLRT2

Austria, Germany, Denmark, Ireland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Allogeneic stem cell transplantation vs. conventional therapy as salvage therapy for relapsed / progressive patients with multiple myeloma after a first-line therapy

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia

Italy, Norway, Slovakia, Austria, Belgium, Germany +6 more

Phase II and Phase III (Integrated) EU CTIS Study details

Vaccination against human papillomavirus (HPV) after allogeneic stem cell transplantation, a randomized study between early and late vaccination.

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Allogeneic Stem Cell Transplantation trials by city

Allogeneic Stem Cell Transplantation in Toronto Allogeneic Stem Cell Transplantation in Vancouver Allogeneic Stem Cell Transplantation in Montreal Allogeneic Stem Cell Transplantation in Calgary Allogeneic Stem Cell Transplantation in Edmonton Allogeneic Stem Cell Transplantation in Ottawa Allogeneic Stem Cell Transplantation in Winnipeg Allogeneic Stem Cell Transplantation in Quebec City Allogeneic Stem Cell Transplantation in Hamilton Allogeneic Stem Cell Transplantation in Kitchener Allogeneic Stem Cell Transplantation in London Allogeneic Stem Cell Transplantation in Halifax Allogeneic Stem Cell Transplantation in New York Allogeneic Stem Cell Transplantation in Los Angeles Allogeneic Stem Cell Transplantation in Chicago Allogeneic Stem Cell Transplantation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease